Atabecestat

CAS No.

1200493-78-2

MDL No.

N/A

C₁₈H₁₄FN₅OS

367.40

InChI Key

VLLFGVHGKLDDLW-SFHVURJKSA-N

Pack Size	Purity	Price	Availability
1 mg	98%	$331	In Stock
5 mg	98%	$732	In Stock
25 mg	98%	$1612	In Stock
100 mg	98%	$2928	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

1 mg

98%

$331

In Stock

5 mg

98%

$732

In Stock

25 mg

98%

$1612

In Stock

100 mg

98%

$2928

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	1200493-78-2
Product Name	Atabecestat

Biological Targets

BACE1

Associated Conditions

Alzheimer disease

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Documentation

Atabecestat

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Related Articles

Discovery of Extremely Selective Fused Pyridine-Derived β-Site Amyloid Precursor Protein-Cleaving Enzyme (BACE1) Inhibitors with High In Vivo Efficacy through 10s Loop Interactions.

Discovery of Atabecestat (JNJ-54861911): A Thiazine-Based β-Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor Advanced to the Phase 2b/3 EARLY Clinical Trial.

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study.

Documentation